Biotech Co. Says Red Cross Plainly Violated Antitrust Law

By Matthew Perlman · May 23, 2023, 5:30 PM EDT

A biotech company defended its suit in Massachusetts federal court accusing the American National Red Cross of snuffing out competition in the platelet bacteria mitigation market, contending the case is straightforward...

To view the full article, register now.

Documents

Case Information

Case Title

Verax Biomedical Inc. v. American National Red Cross

Case Number

1:23-cv-10335

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

February 14, 2023